The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.

Prostaglandins Leukot Essent Fatty Acids

Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Box 644, 601 Elmwood Avenue, Rochester, New York 14642, USA.

Published: May 2010

Lysophophatidylcholine (LPC) and lysophosphatidic acid (LPA) are potent lysolipid mediators increasingly linked with atherosclerosis and inflammation. A current model proposing that plasma LPA is produced when LPC is hydrolyzed by the enzyme autotaxin has not been rigorously investigated in human subjects. We conducted a clinical trial of eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) and aspirin ingestion in normal volunteers. Fasting blood samples were drawn at baseline and after 4-week supplementation with EPA/DHA (3.4 g/d) with and without aspirin (650 mg). Plasma LPC and LPA species and autotaxin activity were measured. EPA-LPC and DHA-LPC concentrations increased significantly with EPA/DHA supplementation whereas EPA- and DHA-LPA did not. Autotaxin activity was unaffected by any treatment, and aspirin had no effect on any endpoint. Taken together, our data demonstrate that plasma LPC, but not LPA, species can be dynamically regulated by dietary supplementation, and argue against a simple model of LPA generation via LPC hydrolysis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926929PMC
http://dx.doi.org/10.1016/j.plefa.2009.12.005DOI Listing

Publication Analysis

Top Keywords

aspirin ingestion
8
plasma lpc
8
lpc lpa
8
lpa species
8
autotaxin activity
8
lpc
5
lpa
5
effects epa
4
epa dha
4
aspirin
4

Similar Publications

Background: Pregnancy is associated with physiological changes that can alter the pharmacokinetic and pharmacodynamic profile of many drugs. Low-dose aspirin is used for preeclampsia prevention; however, aspirin's pharmacokinetics and pharmacodynamics are poorly studied in pregnant women.

Objective: The aim of this study was to compare the pharmacodynamics of 2 common doses of aspirin (75 and 150 mg) used for preeclampsia prevention in high-risk women by examining their effect on thromboxane B inhibition.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how methyl salicylate levels in the blood change after ingestion, aiming to identify peak serum concentrations and factors influencing these levels.
  • Researchers analyzed cases from the Hong Kong Poison Control Centre involving 41 patients, finding that the median time to peak concentration was 5.6 hours, with gastric aspiration and activated charcoal use being linked to lower peak levels.
  • Results suggest that the peak concentration of serum salicylate occurs slower than previously thought, indicating the need for ongoing monitoring in patients after ingestion.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!